p = 0.009) and endoFS (r = -0.320, p = 0.022). In a multivariate linear regression, adjusted for age, diabetes, previous coronary artery disease and logCRP (C-reactive protein), logTSH was an independent correlate with LVEF ( ␤ = -0.388, p ! 0.001). Conclusion: This study suggests that subclinical hypothyroidism is common and might be implicated in cardiac dysfunction in CAPD patients.
Introduction
End-stage renal disease (ESRD) is a frequent cause of alterations in thyroid hormones without any underlying intrinsic thyroid disorder. A variety of alterations in thyroid hormone levels and/or metabolism have been described in patients with chronic kidney disease (CKD) [1, 2] . Serum triiodothyronine (T 3 ) levels are frequently low in dialysis patients, which reflect a diminished conversion of T 4 (thyroxine) to T 3 in the periphery. This abnormality is not associated with an increased conversion of T 4 to the metabolically inactive reverse T 3 (rT 3 ), since se-rum rT 3 levels are typically normal. This finding differentiates uremic patients from those with chronic illness, who are characterized by increased rT 3 [3] .
Subclinical hypothyroidism is biochemically defined as a high serum thyrotropin (TSH) concentration and normal serum free thyroxine (fT 4 ) and T 3 concentrations [4] . It occurs in 5-15% of the general population, and the risk of developing subclinical hypothyroidism increases with female gender, advanced age and greater dietary iodine intake [5] . Depressed left ventricular (LV) systolic function and LV hypertrophy are well-recognized features of subclinical hypothyroidism, and the causal role of thyroid hormone deficiency in cardiomyopathy is indicated by the observation that these alterations revert to normal during L -thyroxine treatment [6] . Also, subclinical hypothyroidism may be associated with increased risks of cardiovascular disease and, possibly, all-cause mortality [7] . In ESRD patients, cardiovascular complications represent the major cause of mortality, and LV systolic dysfunction and LV hypertrophy are powerful predictors of death [8] . In addition, it has been suggested that primary hypothyroidism is more common in this population compared to the general population [1, 2] . However, little is known about the clinical features and implications of subclinical hypothyroidism in patients with ESRD. Therefore, we undertook a cross-sectional study to investigate the clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis (CAPD) patients.
Patients and Methods

Study Population
Out of the 82 prevalent CAPD patients, those who had been on CAPD for less than 3 months and had intercurrent acute illness were excluded. In addition, patients who had previous intrinsic thyroid diseases or were taking drugs known to interfere with thyroid function (i.e. corticosteroids, amiodarone, rifampin, lithium, ␤ -blockers) were excluded. As a result, 51 patients were included in the final analysis.
Patients were treated with 3 or 4 two-liter exchanges per day, using standard dialysates containing glucose. Dialysis prescription aimed at obtaining a total Kt/V of at least 1.7 per week. , where LVIDd, PWTd and SWTd are LV internal dimensions at end diastole, posterior wall thickness at end diastole and septal wall thickness at end diastole, respectively [9] . Left ventricular hypertrophy was defined by a LVMI 1 100 g/m 2 in women or 1 120 g/m 2 in men. Left ventricular ejection fraction (LVEF) was calculated by the 2D method [10] . Fractional shortening at endocardial levels (endoFS) was calculated by the formula: endoFS = (LVEDD -LVESD)/LVEDD ! 100, where LVEDD and LVESD represent the diameter of the left ventricle at end diastole and end systole, respectively). A LVEF ! 50% or a endoFS ! 28% was indicative of LV systolic dysfunction [10] .
In addition, the peak early (E; meters per second) and late (A; meters per second) mitral inflow velocities were measured. With these values, E/A ratios were determined, and diastolic dysfunction was defined as an E/A ratio ! 1.0.
Laboratory Measurements
Serum lipids, albumin, hemoglobin, calcium, phosphate, and C-reactive protein (CRP) were measured by standard methods. Serum T 3 (60-181 ng/dl), fT 4 (0.6-1.5 ng/dl) and TSH (0.35-4.94 mIU/l) were determined by chemiluminescent immunoassay (Hitachi, Tokyo, Japan). Thyroid autoantibody tests (thyroid microsomal Ab and thyroglobulin Ab) were performed by the same method. Subclinical hypothyroidism was defined when the TSH level was over 5 mIU/l with normal fT 4 , and overt hypothyroidism was defined when the TSH level was over 5 mIU/l with decreased fT4 [4] .
Patients were divided into two groups according to TSH levels (normal vs. 6 5 mIU/l). Demographic, clinical and laboratory parameters and echocardiographic findings were compared between the two groups.
Statistical Analysis
The statistical analysis was performed using SPSS version 11.0 (SPSS, Chicago, Ill., USA). All data were expressed as medians with ranges. Data which showed skewed distributions, such as CRP and TSH, were expressed as log transformations. The comparisons between the two groups were made by Student's t test and 2 tests. Relationships between paired parameters were analyzed by Pearson correlation coefficients. The independent association between serum TSH and LV systolic function expressed as LVEF (as a percentage) was analyzed further by multiple linear regression analysis adjusting for other factors with a p value of less than 0.10 on univariate analysis. The level of significance was set at 0.05. Table 1 details characteristics of the 51 patients. The median age of the subjects was 63 years and 51% were male. Diabetes was the most common cause of ESRD (49.0%) and 19 patients (37.3%) had previous coronary artery occlusive diseases (CAOD). The median T 3 and TSH levels were 98 ng/dl and 2.9 mIU/l, respectively. Subclinical hypothyroidism was detected in 14 (27.5%) patients. Only 4 patients (28.6%) among those with subclinical hypothyroidism were identified as having autoim-mune thyroiditis. There was no patient with overt hypothyroidism.
Results
Patient Characteristics
Comparison between Patients with Subclinical Hypothyroidism and Those with Normal TSH Levels
When patients were divided into the two groups on the basis of TSH concentrations, there were no significant differences in the proportions of diabetes, previous CAOD, serum albumin, serum CRP and the lipid profile between the two groups. In addition, weekly Kt/V urea, residual glomerular filtration rate (GFR) and CAPD duration were not different between groups. However, patients with subclinical hypothyroidism were significantly older compared with those with normal TSH levels (58 vs. 68 years old, p ! 0.01). Echocardiographic findings revealed that patients with subclinical hypothyroidism had lower LVEF (62 vs. 70%, p = 0.002) and lower endoFS levels (33.9 vs. 40.0%, p = 0.009) compared to those with normal TSH levels. The LVMI and E/A ratio were not different between the groups ( table 2 ) .
Factors Related to TSH Levels and LV Systolic Function
Bivariate correlation analyses revealed that logTSH was inversely associated with LVEF (r = -0.361, p = 0.009), endoFS (r = -0.320, p = 0.022) and age (r = 0.315, p = 0.026). However, there was no significant correlation between logTSH and logCRP ( fig. 1 ). Multivariate linear regression analyses showed that only LVEF ( ␤ = -0.493, p = 0.007) was identified as a significant correlate with logTSH, adjusting for age, diabetes, serum albumin, previous CAOD and logCRP ( table 3 ) .
In addition, logTSH ( ␤ = -0.388, p = 0.006), logCRP ( ␤ = -0.334, p = 0.036) and previous CAOD ( ␤ = -0.330, p = 0.031) were independently associated with LVEF on the multivariate analysis adjusted for age, diabetes, serum albumin, logCRP, previous CAOD and logTSH ( table 3 ) .
Discussion
In the United States, the National Health and Examination Survey (NHANES III) reported that 4.3% of 16,533 people had subclinical hypothyroidism [11] . In that study, chronic autoimmune thyroiditis was found in 54% of patients with subclinical hypothyroidism. Similarly, a re- port from the UK showed that 67% of females and 40% of males with subclinical hypothyroidism had high serum antithyroid antibody concentrations [12] . Lo et al. [13] examined the prevalence of hypothyroidism in CKD patients using data from NHANES III, and they found an increased prevalence of hypothyroidism in patients with reduced GFR. In addition, with progressively lower GFR, there was a graded and increased likelihood of hypothyroidism. Furthermore, elevated levels of thyroid peroxidase antibodies were less frequently observed at lower GFR. In line with the previous report of Kaptein et al. [1] , our cross-sectional study showed that subclinical hypothyroidism was common (27.5%) in CAPD patients. Interestingly, most subclinical hypothyroidism in our study was non-autoimmune thyroiditis (78.8%), which was similar to the findings of Lo et al. [13] . Recently, Zoccali et al. [22] reported subclinical hypothyroidism in CAPD patients. However, study subjects in their study only presented low fT 3 without elevated TSH; therefore, no subclinical hypothyroidism was evaluated. They appear to be closer to low T 3 syndrome, which is clearly different from subclinical hypothyroidism. By definition, subclinical hypothyroidism is considered as a high serum TSH concentration and normal serum fT 4 and T 3 concentrations [4] . In contrast, we focused on CAPD patients with elevated TSH levels. The reason for the elevated TSH levels in CAPD patients was not clear. Iodide excess due to reduced renal excretion may contribute to the increased frequency of hypothyroidism in ESRD patients [14] . Sato et al. [15] reported that hypothyroidism was reversed after dietary iodine restriction in 83% of 245 Japanese patients with mild to severe renal dysfunction and elevated nonhormonal iodine levels. These patients were characterized by thyroidal iodide organification defects [15] . Another pos- sible reason for the increased frequency of hypothyroidism in CAPD patients was thyroid hormone losses via peritoneal fluid. However, this explanation was contradicted by a report from Robey et al. [16] , indicating that none of the patients were overtly hypothyroid because T 4 and T 3 losses were relatively modest and remained below their daily production rates despite the finding that large amounts of protein are lost in peritoneal fluid [16] . Also, serum TSH levels were mildly elevated in 3 of 9 patients, which was consistent with subclinical hypothyroidism. Our study clearly showed that there were no differences in weekly Kt/V urea, residual GFR and CAPD duration between patients with subclinical hypothyroidism and those with normal TSH levels. This finding implies that elevated TSH levels in patients with subclinical hypothyroidism were not simply explained by clearance difference. CKD or ESRD per se may be associated with increased TSH or reduced thyroid function, in which retained solutes such as organic acids and uremic toxic compounds might play a role.
The present study revealed that CAPD patients with subclinical hypothyroidism had lower LV systolic function compared to those with normal TSH levels, and elevated TSH levels were independently associated with decreased LVEF. A number of sources reported that subclinical hypothyroidism is associated with an increased risk of cardiovascular disease, and, possibly, all-cause mortality [7] . In addition, an impairment in LV function in subclinical hypothyroidism was often recovered by T 4 replacement therapy [17, 18] . Although the exact mechanism of LV dysfunction in subclinical hypothyroidism still remains to be further clarified, our study suggests that subclinical hypothyroidism might be implicated in LV dysfunction in CAPD patients, in a similar way as the general population. Another of the key cardiac manifestations in subclinical hypothyroidism is LV diastolic dysfunction [19] , which is characterized by impaired early ventricular filling on echocardiography. Often, this is associated with a variable impairment in LV systolic function at rest [17, 19] . Our study showed that there were no significant differences in the E/A ratios between patients with subclinical hypothyroidism and those with normal TSH levels, although it was slightly lower in the former (p = 0.087). The reason for this finding is uncertain; however, it can be presumed that, independent of thyroid abnormality, preexisting impaired diastolic function in uremic patients [20] might result in similar E/A ratios between the 2 groups.
Recently, low fT 3 was reported to be implicated in the adverse cardiac effects of inflammation in patients with ESRD [21, 22] . In line with these findings, our study revealed that serum T 3 levels were inversely correlated with logCRP (r = -0.325, p = 0.020, data not shown). Although mechanisms whereby inflammation perturbs thyroid function are still poorly defined, the prevailing view is that nonthyroidal illness is an acute-phase response generated by activation of the cytokine network [23] . However, we could not find a significant relationship of T 3 levels with a decreased LVEF (r = 0.057, p = 0.691, data not shown), which is not consistent with Zoccali et al. [24] . This discrepancy could be partly explained by the lower proportion of patients with low T 3 levels, the shorter dialysis duration (9 vs. 43 months) of our subjects and different dialysis modalities provided between the 2 studies, which might lead to a difference in microinflammation. Actually, serum CRP levels in our subjects were much lower than those in their subjects, although clear comparisons could not be made.
There are several limitations to this study. First, this is a cross-sectional study with a small sample size. As a cross-sectional study design, all data were collected at a single time, which might not yield a precise patient status. Hence, the causality of our findings needs further confirmation. The small sample size is another drawback that might lead to selection bias. Despite these limitations, it should be noted that subclinical hypothyroidism was significantly associated with LV systolic dysfunction in this study. To our knowledge, there has been no report about the relationship between subclinical hypothyroidism and LV systolic dysfunction in CAPD patients.
In conclusion, our study showed that subclinical hypothyroidism was prevalent and autoimmune thyroiditis was a less common cause of subclinical hypothyroidism in CAPD patients. Elevated TSH levels were significantly related to LV systolic dysfunction in CAPD patients. Therefore, further prospective studies will be needed to elucidate the effects of subclinical hypothyroidism on cardiac dysfunction in ESRD patients.
